help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 30, 2009
Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2009-0384
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
94/9/3289    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Bakalov, V. K.
Right arrow Articles by Bondy, C. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bakalov, V. K.
Right arrow Articles by Bondy, C. A.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Female Endocrinology

Submitted on February 25, 2009
Accepted on June 18, 2009

X-CHROMOSOME GENE DOSAGE AND THE RISK OF DIABETES IN TURNER SYNDROME

Vladimir K. Bakalov*, Clara Cheng, Jian Zhou, and Carolyn A. Bondy

Program in Developmental Endocrinology and Genetics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892

* To whom correspondence should be addressed. E-mail: bakalov{at}mail.nih.gov.

Background: Turner syndrome (TS) is caused by the absence or fragmentation of the 2nd sex chromosome. An increased risk of diabetes mellitus (DM) has consistently been noted, but the specific phenotype and genetic etiology of this trait are unknown.

Methods: In a prospective study, we examined the prevalence of DM in adult participants in an intramural NIH TS study. Results were analyzed with respect to karyotype, age, BMI and autoimmune indices. Insulin sensitivity and secretion were compared in age- and BMI-matched euglycemic women with TS and healthy female controls. We compared gene expression profiles in lymphocytes from differentially affected TS groups.

Results: Type 2 DM was present in 56/224 (25%) of women with TS; type 1 DM was found in only one (<0.5%). DM was more prevalent among women with an isoXq chromosome compared to X monosomy (40.0% vs. 17.3%, p=0.004). Euglycemic women with TS (n=72; age 33±12; BMI 23±3) had significantly higher glycemic and lower insulin responses to OGTT, with insulin sensitivity similar to controls. Gene expression profiles comparing 46,X,i(X)q vs. 45,X groups showed a significant increase in Xq transcripts and in potentially diabetogenic autosomal transcripts in the isoXq group.

Conclusion: Type-2 DM associated with deficient insulin release is significantly increased among women with monosomy for the X chromosome, but is even more greatly increased among women with monosomy for Xp coupled with trisomy for Xq. These data suggest that haploinsufficiency for unknown Xp genes increases risk for DM and that excess dosage of Xq genes compounds the risk.


Key words: diabetes mellitus • impaired glucose tolerance • insulin • {beta}-cell • X-chromosome







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society